Legal Representation
Attorney
Jonathan Feuchtwang
USPTO Deadlines
Next Deadline
1878 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250218)
Due Date
February 18, 2031
Grace Period Ends
August 18, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
40 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 18, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Feb 18, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 23, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jan 23, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Oct 2, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Aug 1, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 2, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 1, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Jul 30, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 4, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 4, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 15, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 30, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 5, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 4, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 4, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Apr 2, 2024 | RDX3 | O | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | Loading... |
| Apr 2, 2024 | RDX1 | O | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | Loading... |
| Apr 2, 2024 | RRDX | W | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | Loading... |
| Mar 6, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 6, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 6, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Mar 6, 2024 | RDX3 | O | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | Loading... |
| Mar 6, 2024 | RDX1 | O | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | Loading... |
| Mar 6, 2024 | RRDX | W | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | Loading... |
| Mar 5, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 5, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 5, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Feb 16, 2024 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Feb 16, 2024 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Feb 16, 2024 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Sep 13, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 12, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 12, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 8, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Sep 8, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Sep 8, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 5, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 28, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 26, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for delivery to solid organ tumors; implant subcutaneous drug delivery devices sold filled with pharmaceutical preparations for extended release of anti-androgen drugs directly to prostate tissue
First Use Anywhere:
Feb 1, 2024
First Use in Commerce:
Feb 1, 2024
Class 010
Medical device for treating cancer
First Use Anywhere:
Feb 1, 2024
First Use in Commerce:
Feb 1, 2024
Classification
International Classes
005
010